Inhibitor of apoptosis (IAP) proteins: novel insights into the cancer-relevant targets for cell death induction.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  ACS Chemical Biology

• Publication date

  2009-07-09

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/cb900150gPMID 19588916
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2.

  2009cited by this paper
• Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists.

  2009cited by this paper
• cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination.

  2008cited by this paper
• IAP-targeted therapies for cancer

  2008cited by this paper
• Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis.

  2007cited by this paper
• IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.

  2007cited by this paper
• IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.

  2007cited by this paper
• Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family

  2006cited by this paper
• The Human Anti-apoptotic Proteins cIAP1 and cIAP2 Bind but Do Not Inhibit Caspases*

  2006cited by this paper

• Codelivery of Cell Apoptosis AVPIAQ Peptide and Doxorubicin for Synergistic Cancer Therapy.

  2025cites this paper
• The expanding role of IAP antagonists for the treatment of head and neck cancer

  2023cites this paper
• Copper-imidazo[1,2-a]pyridines induce intrinsic apoptosis and modulate the expression of mutated p53, haem-oxygenase-1 and apoptotic inhibitory proteins in HT-29 colorectal cancer cells

  2019cites this paper
• Acute Sensitivity of Ph-like Acute Lymphoblastic Leukemia to the SMAC-Mimetic Birinapant.

  2016cites this paper
• Targeting AML stem/progenitor cells by combinational therapy with SMAC mimetics and demethylating agents

  2015cites this paper
• Oncoapoptotic signaling and deregulated target genes in cancers: special reference to oral cancer.

  2013cites this paper
• Design and synthesis of potent inhibitor of apoptosis (IAP) proteins antagonists bearing an octahydropyrrolo[1,2-a]pyrazine scaffold as a novel proline mimetic.

  2013cites this paper
• Discriminative eradication of cancer cells using quantum dots functionalised with peptide-directed delivery of a pro-apoptotic peptide

  2013cites this paper
• New therapeutic targets in the intrinsic apoptotic pathway in neuroblastoma

  2012cites this paper
• Differential regulation of T cell responses by pathogenic and apathogenic microorganisms

  2012cites this paper
• UvA-DARE ( Digital Academic Repository ) New therapeutic targets in the intrinsic apoptotic pathway in neuroblastoma

  2012cites this paper
• Chemoprevention, chemotherapy, and chemoresistance in colorectal cancer

  2012cites this paper
• Solid-phase synthesis of an apoptosis-inducing tetrapeptide mimicking the Smac protein

  2011cites this paper
• Proteome-wide prediction of overlapping small molecule and protein binding sites using structure.

  2011cites this paper
• Solid-phase synthesis of smac peptidomimetics incorporating triazoloprolines and biarylalanines.

  2011cites this paper
• Screening multicomponent reactions for X-linked inhibitor of apoptosis-baculoviral inhibitor of apoptosis protein repeats domain binder.

  2011cites this paper
• The Role of Apoptosis in the Pathology of Pancreatic Cancer

  2010cites this paper